On Aug 9, 2013, Zacks Investment Research upgraded
MWI Veterinary Supply Inc.
) - a leading distributor of animal health products to
veterinarians - to a Zacks Rank #2 (Buy). The upgrade came on the
back of MWI Vet's consistently better-than-expected quarterly
results in the recent past.
Why the Upgrade?
MWI Vet witnessed rising earnings estimates on the back of
excellent third-quarter fiscal 2013 results. The earnings beat in
the third quarter represented the seventh successive quarterly
This Meridian, Ida.-based company delivered positive earnings
surprises in all of the last four quarters with an average beat
of 5.29%. The long-term expected earnings growth rate for this
stock also stands at an impressive 14.8%. Despite the drought
conditions in the U.S. production animal market, the company's
revenues have consistently moved north over the last few
In addition, MWI Vet has been trying to focus on value-added
services, including the e-commerce platform and pharmacy
fulfillment programs for both production and companion animal
products.The company's organic growth in the U.S. was driven by
its prompt customer service, rapid adoption of the e-commerce
platform by veterinarians and strong performance of the sales
force. We believe that these key strategies hold immense
potential for the company's future growth.
The Zacks Consensus Estimate for 2013 has increased by 1.2% to
$4.93 per share, as all the estimates were revised higher over
the last 30 days.
Stocks to Consider
Other medical devices companies that are expected to
outperform in the near term are
). All three stocks carry a Zacks Rank #1 (Strong Buy).
ALERE INC (ALR): Free Stock Analysis Report
CYBERONICS INC (CYBX): Free Stock Analysis
MWI VET SUPPLY (MWIV): Free Stock Analysis
THORATEC CORP (THOR): Free Stock Analysis
To read this article on Zacks.com click here.